In patients with endosseous dental implants that demonstrate peri-implantitis, does surgical bone augmentation with adjunctive laser implant surface disinfection have an effect on implant survival rates, and do these rates differ based on laser treatment modality?
Background
A large number of dental implants are placed currently, and although they have been shown to be a predictable treatment modality to replace missing teeth, 1 reports indicate that up to 12% to 43% of dental implants will develop clinical signs and symptoms of peri-implantitis and crestal bone loss over 5 or more years after functional loading. 2, 3 Treatment strategies for management and treatment of peri-implantitis have been varied, and there is little evidence of treatment efficacy. 4 A consensus report of the 6th European Workshop on Periodontology stated that non-surgical therapy of peri-implantitis has not been found to be effective. 5 Conversely, surgical outcomes with guided bone regeneration (GBR) have demonstrated improved clinical and radiographic outcomes for periimplantitis treatment. [6] [7] [8] [9] The adjunctive use of laser and photodynamic therapy (PDT) has also been considered to improve implant surface decontamination with both surgical and non-surgical therapy. [10] [11] [12] 
Search Strategy
The following terms were searched in the PubMed database (in which mh is the MeSH term, tw is the text word, pt is the publication type, and sb is the subset): Peri-Implantitis OR peri-implantitis OR perimplantitis OR peri-implant OR peri-implant OR perimplant OR (Dental Implantation OR Dental Implants) AND (Prosthesis- 
Search Outcome
Ninety-six abstracts were hand reviewed, and 19 full-text articles were reviewed. Four articles are included in this review. Original human participant case series, cohort, and randomized controlled trials were included. Papers were eliminated for the following reasons: 1) study design; 2) lack of published data on peri-implantitis treatments; 3) non-unique patient populations; and 4) surgical access only with laser debridement. Data for guided tissue regeneration (GTR) with laser implant surface debridement were extracted from datasets if the following were true: 1) additional treatment modalities were included in the manuscripts; 2) findings were reported; and 3) those specific data are reported in this report. The findings of the relevant current literature [13] [14] [15] [16] are reviewed in Table 1 .
Discussion
Commercially available lasers that have been used for implant surface disinfection include carbon dioxide (CO 2 ), diode, erbium:yttrium-aluminum-garnet (Er:YAG), and neodymium:yttrium-aluminum-garnet (Nd:YAG). Current evidence demonstrates inconsistent data regarding laser reduction of bacterial loads on tooth surfaces beyond that achieved with non-surgical periodontal therapy alone. 17, 18 However, in vitro and in vivo trials have demonstrated elimination of bacterial smear layer and viable bacteria with the use of laser therapy. [19] [20] [21] [22] Although non-surgical treatment of peri-implantitis with the adjunctive use of laser treatment was not found to be effective in a previous review, 5 surgical access with surface debridement and bone augmentation has been shown to be effective. 6, 7 Variability within the treatment outcomes may be influenced by implant surface characteristics, bone graft substitute qualities, and defect characteristics. 8, 23 One article reviewed 16 was a randomized controlled trial, but the manuscript only presented clinical data at baseline and follow-up. Surgical reentry data were available in one article reviewed, 14 although patient assignment to treatment groups was not stated to be randomized in this study. A total of 86 implants were treated with GBR and laser implant surface decontamination in all articles reviewed, and the total follow-up time ranged from 0 to 60 months. Considerable heterogeneity exists in evaluation procedures for resolution of peri-implantitis in the articles reviewed, and none of the articles evaluated microbiologic outcomes. All articles reviewed demonstrated an improvement in clinical and/or radiographic outcomes from baseline to follow-up for ailing implants treated with laser and GBR protocols. Furthermore, the two studies that demonstrated comparative results for implants treated with GBR without laser debridement demonstrated improved clinical and/or radiographic outcomes for the laser decontamination group when compared with standard decontamination. 14, 16 Because the articles reviewed used varied laser protocols, including CO 2 , 14,15 Er:YAG, 16 and soft light laser at 906 nm, 13 no meaningful conclusions can be made about the effectiveness of individual laser types for decontamination purposes from these studies. In vitro and animal studies have suggested that low-level laser with dye may improve implant surface disinfection. 12, 24, 25 Furthermore, in vitro studies have shown that diode, CO 2 , Er:YAG, and Nd:YAG lasers at appropriate wavelength settings may be sufficient to reduce and/or eliminate surface bacteria without damaging implant surface characteristics if appropriate published parameters are used. 26, 27 Implant failure has been classified into clinically distinct types with differing microbiota based on the underlying etiology. 28 Early implant failure may be associated with lack of primary stability, surgical trauma, or postoperative infection, whereas late failure has been shown to be associated with occlusal overload and peri-implantitis. 29, 30 In one article reviewed, 15 15 of the 19 implants treated demonstrated bone loss before Phase II uncovery procedures and prosthetic restoration. These implants may represent a different subset of microbiota than those with late and/or infectionrelated failures and may respond differently to therapy. Evaluation of specific microbiota associated with periimplantitis, specifically Tannerella forsythia, Campylobacter FIGURE 1 Bitewing radiograph demonstrating radiographic bone loss of 40% to 60% of implant length at both the mesial and distal surfaces of implant #20.
FIGURE 2
Intrasurgical clinical photograph taken after debridement demonstrating a circumferential bony defect at implant #20. spp., and Parvimonas micra, and evaluation of loss of radiographic lamina dura 31 in future investigations may allow for more certainty in the diagnosis of late implant failure, i.e., true peri-implantitis. GBR alone has been used in both animal and human models to treat peri-implant defects. 8, 9, [32] [33] [34] [35] [36] [37] Furthermore, bone replacement grafting has demonstrated differing success on various implant surface types. 37 Bone substitute materials, defect morphology, and implant surface characteristics may all influence clinical outcomes of peri-implantitis treatment with GBR. Participants in the studies reviewed received grafting with autogenous bone, xenograft, and alloplast materials, and numerous implant surface types were included in the treated implant group. The heterogeneity of implant systems and surface types, bone replacement graft materials used, and possible varied etiologies for peri-implant bone loss are confounders when evaluating the current literature.
B E S T -E V I D E N C E T O P I C
One study included in this review demonstrated longterm follow-up with a randomized controlled trial design. 9 Previous data were published on the short-term (6-month) results after Er:YAG laser surface decontamination. 23 Although 6-month data demonstrated higher reduction in bleeding on probing (BOP) and clinical attachment level (CAL) at the laser disinfected sites, at 24 months, there were no statistically significant differences between the groups, and neither group demonstrated CAL levels that differed from baseline findings. These results may indicate that adjunctive laser disinfection may result in short-term decontamination and improved clinical findings, but the longevity of these effects may not allow long-term improvements at implants with peri-implantitis.
There have also been adverse events associated with implant treatment with lasers. Nd:YAG lasers have been shown in some studies to boil additive implant surfaces, yielding porosities, which could serve as a niche for additional bacterial proliferation. 38, 39 Additionally, the use of CO 2 lasers at pulsed and continuous settings has been demonstrated to raise the temperature of implants in vitro 9.5˚C to 12.2˚C, respectively. 40 This type of increase in temperature from physiologic 37˚C could yield local circumimplant temperatures in the range of bone necrosis. Furthermore, variability in wavelength, pulse, and irrigation have been shown to have demonstrative effects on decontamination effectiveness and alterations to surface chemistry. 41 Some of the risks of laser therapy may be mitigated by the use of PDT, which uses low-level laser therapy to perform surface decontamination. A recent in vitro study indicated that PDT may be more efficient than standard laser disinfection protocols without many of the associated risks. 12 Therefore, it is very important to note the time, wavelength, presence of cooling, and power of lasers used for peri-implantitis treatment when adapting a published laser treatment protocol for clinical application. n
Clinical Bottom Line
Adjunctive use of laser disinfection protocols with GTR for the treatment of peri-implantitis may improve clinical and radiographic findings up to 5 years after therapy. Significant heterogeneity exists in implant decontamination protocols. Care must be taken to develop standardized, ideal laser decontamination protocols that fully characterize the wavelength, time, power, and presence of cooling that may yield ideal results for peri-implantitis treatment. Additional longitudinal studies are necessary to allow for the development of standardized protocols for surgical treatment of peri-implant bone loss and clinical inflammation. ePTFE ¼ expanded polytetrafluoroethylene; PD ¼ probing depth; DIB ¼ distance from implant platform to first implant bone contact radiographically.
